Incidence of hyperlipidemia in kidney transplant patients treated with a combination regimen of sirolimus(Rapa)-cyclosporine(CsA)-prednisone(Pred)

被引：3
|
作者：
Suri, A
Kahan, BD
机构：
[1] Univ Texas, Sch Med, Div Immunol & Organ Transplantat, Houston, TX 77030 USA
[2] Univ Texas, Sch Med, Div Nephrol, Houston, TX 77030 USA
来源：
TRANSPLANTATION | 1999年 / 67卷 / 07期
关键词：
D O I：
10.1097/00007890-199904150-00671
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
646
引用
下载
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [11] Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine
    Machado, PGP
    Felipe, CR
    Park, SI
    Garcia, R
    Moreira, S
    Casarini, D
    Franco, M
    Alfieri, F
    Tedesco-Silva, H
    Medina-Pestana, JO
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2004, 37 (09) : 1303 - 1312
  • [12] The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients
    Murgia, MG
    Jordan, S
    Kahan, BD
    KIDNEY INTERNATIONAL, 1996, 49 (01) : 209 - 216
  • [13] Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: Incidence, risk factors, progression, and prognosis
    Chueh, SCJ
    Kahan, BD
    TRANSPLANTATION, 2003, 76 (02) : 375 - 382
  • [14] Zeta chain expression on T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS) treated with cyclosporine a (CSA) and prednisone (PRED)
    Musial, Kinga
    Zwolinska, Danuta
    Ciszak, Lidia
    Kosmaczewska, Agata
    Szteblich, Aleksandra
    Pawlak, Edyta
    Frydecka, Irena
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 238 - 238
  • [15] Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients
    Langer, RM
    Kahan, BD
    TRANSPLANTATION, 2002, 74 (06) : 804 - 808
  • [16] De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine a sirolimus combination
    Langer, RM
    Van Buren, CT
    Katz, SM
    Kahan, BD
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3236 - 3237
  • [17] CHARACTERIZATION OF SEVERE CARDIAC TRANSPLANT REJECTION IN PATIENTS TREATED WITH CYCLOSPORINE AND PREDNISONE
    MURDOCK, DK
    SCHREIBER, RR
    OCONNELL, JB
    NORDIN, MRC
    SCANLON, PJ
    MONTOYA, A
    PIFARRE, R
    CLINICAL RESEARCH, 1985, 33 (04): : A868 - A868
  • [18] Is cyclosporine-sirolimus combination actually associated with renal ipairment in kidney transplant recipients?
    Mahalati, K
    Kahan, BD
    TRANSPLANTATION, 2000, 69 (08) : S153 - S153
  • [19] Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients
    Kahan, BD
    Yakupoglu, YK
    Schoenberg, L
    Knight, RJ
    Katz, SM
    Lai, D
    Van Buren, CT
    TRANSPLANTATION, 2005, 80 (06) : 749 - 758
  • [20] LOW DOSE CYCLOSPORINE AND SIROLIMUS REGIMEN IN RENAL TRANSPLANT PATIENTS - SINGLE CENTER EXPERIENCE
    Lucan, Mihai M.
    Partiu, Alina
    Muntean, Adriana
    Lucan, Ciprian V.
    Elec, Florin
    Iacob, Gheorghita
    Barbos, Adrian
    TRANSPLANT INTERNATIONAL, 2009, 22 : 239 - 239
12345